Electrical nerve stimulator

Ito , et al. Oc

Patent Grant D863573

U.S. patent number D863,573 [Application Number D/642,811] was granted by the patent office on 2019-10-15 for electrical nerve stimulator. This patent grant is currently assigned to OMRON HEALTHCARE Co., Ltd.. The grantee listed for this patent is OMRON HEALTHCARE Co., Ltd.. Invention is credited to Kazuya Andachi, Tamaki Ito, Tsuyoshi Ogihara, Takashi Shigeno, Gen Suzuki.


United States Patent D863,573
Ito ,   et al. October 15, 2019

Electrical nerve stimulator

Claims

CLAIM The ornamental design for an electrical nerve stimulator, as shown and described.
Inventors: Ito; Tamaki (Muko, JP), Ogihara; Tsuyoshi (Muko, JP), Suzuki; Gen (Kamakura, JP), Shigeno; Takashi (Tokyo, JP), Andachi; Kazuya (Tokyo, JP)
Applicant:
Name City State Country Type

OMRON HEALTHCARE Co., Ltd.

Muko

N/A

JP
Assignee: OMRON HEALTHCARE Co., Ltd. (JP)
Appl. No.: D/642,811
Filed: April 2, 2018

Foreign Application Priority Data

Oct 3, 2017 [JP] 2017-021901
Current U.S. Class: D24/200
Current International Class: 2803
Field of Search: ;D24/200,186-187,168,214-215

References Cited [Referenced By]

U.S. Patent Documents
D255149 May 1980 Bevilacqua
D383212 September 1997 Okabe
D394906 June 1998 Lange et al.
D402762 December 1998 Szpur
D412751 August 1999 Davis et al.
D413168 August 1999 Davis et al.
D432240 October 2000 Katz et al.
D484984 January 2004 Takizawa et al.
7069089 June 2006 Minogue et al.
D534871 January 2007 Larsen
D566288 April 2008 Chuang
D571476 June 2008 Chuang
D584414 January 2009 Lash et al.
D600352 September 2009 Cryan
D625016 October 2010 Potts et al.
D626244 October 2010 Sagnip et al.
8086318 December 2011 Strother et al.
8386032 February 2013 Bachinski et al.
8452409 May 2013 Bachinski et al.
D704848 May 2014 Thomas et al.
D706429 June 2014 Julian et al.
D712052 August 2014 Thomas et al.
8798739 August 2014 Bachinski et al.
D713049 September 2014 Shah
D716457 October 2014 Brefka et al.
8972016 March 2015 Thomas et al.
8977366 March 2015 Bachinski et al.
D726924 April 2015 Tseng et al.
9044587 June 2015 Bachinski et al.
D735873 August 2015 Brefka et al.
D740428 October 2015 Suzuki
D745975 December 2015 Igaue et al.
9220896 December 2015 Bachinski et al.
9283371 March 2016 Duncan
D754355 April 2016 Ganapathy et al.
D759830 June 2016 Guarraia et al.
D760395 June 2016 Barbaric et al.
D760397 June 2016 Guarraia et al.
9381353 July 2016 Bachinski et al.
D763107 August 2016 Nielsen et al.
D763455 August 2016 Hesse
9415217 August 2016 Chen
D775361 December 2016 Vosch et al.
D780316 February 2017 Pukall
D782053 March 2017 Ferguson-Shakir
9616234 April 2017 Harry et al.
9630013 April 2017 Bachinski et al.
D793566 August 2017 Bishay et al.
D794805 August 2017 Kranz et al.
D794806 August 2017 Kranz et al.
D794807 August 2017 Kranz et al.
9737705 August 2017 Bachinski et al.
D797301 September 2017 Chen
D798170 September 2017 Toth et al.
D810311 February 2018 Chen
D810952 February 2018 Hsu
D821595 June 2018 Ito
10076662 September 2018 Tuan
D834719 November 2018 Theriot
D837394 January 2019 Cryan
2008/0065182 March 2008 Strother et al.
2010/0305669 December 2010 Sasaki
2013/0197341 August 2013 Grob et al.
2013/0317333 November 2013 Yang et al.
2014/0206976 July 2014 Thompson et al.
2014/0296934 October 2014 Gozani et al.
2014/0309709 October 2014 Gozani et al.
2015/0238094 August 2015 Lai et al.
2016/0008597 January 2016 Chen
2016/0074658 March 2016 Bachinski et al.
2016/0101284 April 2016 Bachinski et al.
2016/0346543 December 2016 Chen
2017/0188872 July 2017 Hughes et al.
2017/0209693 July 2017 An et al.
2017/0224990 August 2017 Goldwasser et al.
2017/0368345 December 2017 Kong et al.

Other References

Aleve Direct Therapy; Retrieved from www.aleve.com; Retrieved on Apr. 9, 2018; https://www.aleve.com/aleve-direct-therapy/; Apr. 2016 (Year: 2016). cited by applicant .
U.S. Appl. No. 29/596,905, filed Mar. 13, 2017. (Unpublished). cited by applicant.

Primary Examiner: Laymon; Wan
Attorney, Agent or Firm: Saidman DesignLaw Group, LLC

Description



FIG. 1 is a perspective view of an electrical nerve stimulator showing our new design;

FIG. 2 is a left side view thereof;

FIG. 3 is a right side view thereof;

FIG. 4 is a top view thereof;

FIG. 5 is a bottom view thereof;

FIG. 6 is a front view thereof; and,

FIG. 7 is a rear view thereof.

The broken lines illustrate structure or features which form no part of the claimed design.

* * * * *

References

Patent Diagrams and Documents

D00000


D00001


D00002


D00003


D00004


XML


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed